Peter the Bridge, Saint Petersburg, Russia

The NEOMED Institute is proud to be a Gold Sponsor of the 8th BioConnect Symposium jointly organized with the International Biotechnology Symposium (IBS2018)

June 28th, 2018 |Announcement| No Comments

The NEOMED Institute is pleased to announce its partnership with the BioConnect symposium, which will take place on August 16, 2018, as part of the International Biotechnology Symposium and Exhibition (IBS2018), at the Palais des congrès de Montréal (Montreal Convention Centre).


Montreal (QC), June 28, 2018 – Organized by the McGill Biotechnology Graduate Students Society (BtGSS) the overarching theme of this eighth BioConnect Symposium is “BioConnecting Academia and Industry” aiming to foster collaboration between academia and industry. This year’s symposium will emphasize the current prospects of biotechnology and biology-related fields in both academia and industry as well as explore the future and growth of this field.

“We are very proud to support McGill’s graduate student, for us it is important to encourage the new generation of researchers. This sponsorship with BioConnect is perfectly in line with NEOMED’s mission, which is to enable and accelerate the commercialization of Quebec and Canadian scientific discoveries.” declared Donald Olds, President and CEO of NEOMED Institute.

BioConnect Symposium is in conjunction with the 18th International Biotechnology Symposium (IBS2018), which will take place in Montreal for the very first time from August 12th to 17th , 2018. IBS2018 is an opportunity to discover the latest trends in biotechnology, to exchange ideas with participants from 50 countries, and take in over 150 presentations over the four days of the event.

This event will bring together diverse research and applications of biotechnology under one roof. The symposium will provide a unique, international forum for the exchange of ideas and cross-pollination among peers, combined with a social program to facilitate networking and discover Canada’s cultural capital.


About BioConnect 2018

Website :

Where : Palais des congrès de Montréal (Montreal Convention Centre)

When : August 16th2018


About IBS2018

Website :

Early bird registrants save $200 before July 3, 2018.

Where : Palais des congrès de Montréal (Montreal Convention Centre)

When : August 12thto 17th2018


About the NEOMED Institute –

The NEOMED Institute is a successful and innovative Canadian not-for-profit R&D organization whose mission is to enable and accelerate the commercialization of life science discoveries. To accomplish this mission, NEOMED Institute operates two complementary and integrated divisions:

  • NEOMED Therapeutics in-licenses promising scientific discoveries from Canadian university centres and research institutes and then funds and develops these programs to stages that are attractive for partnering or stand-alone financing. All proceeds are then re-invested in new projects.
  • NEOMED Innovation Centre operates a world-class life sciences ecosystem in Montréal, Quebec. Today the NEOMED Innovation Centre hosts 30 life sciences companies employing over 350 people who operate in our two state-of-the-art R&D centres comprising over 200,000 sq. ft. of fully equipped laboratories and benefit from NEOMED’s shared services model (analytical chemistry, in vivo pharmacology, etc.) that enables an entrepreneurial culture of collaboration and scientific innovation.

The NEOMED Institute is funded by pharmaceutical partners, Quebec’s Ministry of the Economy of Science and Innovation, and the Networks of Centres of Excellence (NCE) of Canada as well as from revenue generated from the out-licensing/sale of the research pipeline projects and the operation of facilities.


For more information :

Shirley Robinet
Communications Coordinator
Tel.: 514-367-1212 ext. 218

Share this

Similar News

image articles
30 May 2019

CDRD and NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovations

Read complete news
image articles
14 May 2019

Hope on the horizon for hard-to-treat breast cancers

Read complete news
© 2019 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia